Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1999 2
2001 4
2002 5
2003 5
2004 4
2005 4
2006 10
2007 10
2008 11
2009 19
2010 10
2011 18
2012 9
2013 10
2014 19
2015 12
2016 15
2017 11
2018 2
2019 7
2020 11
2021 8
2022 12
2023 2
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Health Technology Assessment del vaccino ricombinante adiuvato contro il virus respiratorio sinciziale (Arexvy®).
Calabrò GE, Rizzo C, Domnich A, DE Waure C, Rumi F, Bonanni P, Boccalini S, Bechini A, Panatto D, Amicizia D, Amodio E, Costantino C, Bert F, Lo Moro G, DI Pietro ML, Giuffrida S, Giordano V, Conversano M, Russo C, Spadea A, Ansaldi F, Grammatico F, Ricciardi R, Torrisi M, Porretta AD, Arzilli G, Scarpaleggia M, Bertola C, Vece M, Lupi C, Lorenzini E, Massaro E, Tocco M, Trapani G, Zarcone E, Munno L, Zace D, Petrella L, Vitale F, Ricciardi W. Calabrò GE, et al. Among authors: ansaldi f. J Prev Med Hyg. 2024 Jun 30;65(2 Suppl 1):E1-E159. doi: 10.15167/2421-4248/jpmh2024.65.2s1. eCollection 2024 Sep. J Prev Med Hyg. 2024. PMID: 39554593 Free PMC article. Italian. No abstract available.
Vaccine-preventable infections in Systemic Lupus Erythematosus.
Murdaca G, Orsi A, Spanò F, Faccio V, Puppo F, Durando P, Icardi G, Ansaldi F. Murdaca G, et al. Among authors: ansaldi f. Hum Vaccin Immunother. 2016 Mar 3;12(3):632-43. doi: 10.1080/21645515.2015.1107685. Hum Vaccin Immunother. 2016. PMID: 26750996 Free PMC article. Review.
Vaccine-preventable diseases: from paediatric to adult targets.
Esposito S, Durando P, Bosis S, Ansaldi F, Tagliabue C, Icardi G; ESCMID Vaccine Study Group (EVASG). Esposito S, et al. Among authors: ansaldi f. Eur J Intern Med. 2014 Mar;25(3):203-12. doi: 10.1016/j.ejim.2013.12.004. Epub 2014 Jan 2. Eur J Intern Med. 2014. PMID: 24389370 Review.
Universal influenza virus vaccines: what needs to happen next?
Trucchi C, Paganino C, Amicizia D, Orsi A, Tisa V, Piazza MF, Icardi G, Ansaldi F. Trucchi C, et al. Among authors: ansaldi f. Expert Opin Biol Ther. 2019 Jul;19(7):671-683. doi: 10.1080/14712598.2019.1604671. Epub 2019 Apr 22. Expert Opin Biol Ther. 2019. PMID: 30957589 Review.
COVID-19: Some clinical questions after the first 4 months.
Bassetti M, Ansaldi F, Icardi G, Pelosi P, Robba C, Taramasso L, Trucchi C, Vena A, Giacobbe DR. Bassetti M, et al. Among authors: ansaldi f. Eur J Clin Invest. 2020 Jul;50(7):e13326. doi: 10.1111/eci.13326. Epub 2020 Jul 5. Eur J Clin Invest. 2020. PMID: 32562550 Free PMC article. No abstract available.
Pneumococcal vaccination in Europe: schedule adherence.
Gervaix A, Ansaldi F, Brito-Avô A, Azzari C, Knuf M, Martinón-Torres F, Tuerlinckx D, Tin Htar MT, Syrogiannopoulos GA. Gervaix A, et al. Among authors: ansaldi f. Clin Ther. 2014 May;36(5):802-12.e1. doi: 10.1016/j.clinthera.2014.03.001. Epub 2014 Apr 18. Clin Ther. 2014. PMID: 24746990
206 results